Praveen R. Jeyarajah - Investment Team
Prior to joining Astor Place Holdings, Mr. Jeyarajah was the Executive Vice President, Corporate Development at Rexnord Corporation, a diversified industrial company with $2 billion in annual sales. Prior to Rexnord Corporation, he was a Managing Director at Cypress Group, LLC. Mr. Jeyarajah was also a Managing Director in The Carlyle Group's U.S. leveraged buyout fund, focused on industrial investments. Mr. Jeyarajah has a B.A. from Rutgers College and an M.B.A. from The Wharton School of Business.
Charles P. Durkin III - Investment Team
Prior to joining Astor Place Holdings, Mr. Durkin was an Analyst on the long-only and long/short equity portfolios at Select Equity Group since 2009 and was an intern in 2001. Prior to joining Select Equity Group, Mr. Durkin worked for five years in the U.S. Senate and as the Personal Aide to the Vice President of the United States. Mr. Durkin received an A.B. from Princeton University.
Tatyana Nowicki - Investment Team
Prior to joining Astor Place Holdings, Ms. Nowicki was an Associate with The Carlyle Group's U.S. leveraged buyout fund, where her primary responsibilities included the evaluation, execution and monitoring of investments in the consumer/retail sector. Prior to The Carlyle Group, she worked in the Mergers & Acquisitions group at Evercore Partners. Ms. Nowicki received her B.S. from NYU Stern School of Business.
Mark Adams - Investment Team
Prior to joining Astor Place Holdings, Mr. Adams was an Associate at Clearview Capital, a middle market leveraged buyout firm, where his primary responsibilities included the evaluation, execution and monitoring of investments across a variety of industries. Prior to Clearview, he worked as a Generalist Investment Banking Analyst at Stephens Inc. Mr. Adams received a B.A. from the University of Pennsylvania.
Simeon Ketchum - Capital Formation and IR
Prior to joining Astor Place Holdings, Mr. Ketchum was a Managing Director at Whitehall & Co, an investment bank, and previously ran capital formation for Glenfarne Group, an energy and infrastructure private equity organization. Prior to Glenfarne, he was at Credit Suisse where he focused on private placements, equity co-investments and M&A while leading institutional family office investment banking coverage. Mr. Ketchum was previously with UBS Investment Bank in its Global Industrials Group and with BB&T Capital Markets. He began his career with Brown Brothers Harriman. Mr. Ketchum received a B.A. from Trinity College (CT) and an M.B.A. from Vanderbilt University’s Owen Graduate School of Management.
Heather J. Moore - Operations
Prior to joining the private investment arm of Select Equity, Ms. Moore was a Master Scheduler at MacAndrews & Forbes Inc. Prior to MacAndrews & Forbes Inc., she was an Event Planner and Manager for the US Department of Defense Recovering Warrior Task Force. Ms. Moore also worked as a Program Planner for the Near East South Asia Center for Strategic Studies at the National Defense University. Ms. Moore received a B.A. from the University of Connecticut.
James A. Graner - Senior Advisor
James A. Graner has 41 years of experience working at Graco Inc., a diversified industrials company with $1.3 billion in sales. Most recently, he served as Chief Financial Officer of Graco Inc. from 2005 to 2015, part of an executive leadership team that grew Graco from $732 million to $1.3 billion in sales. Prior to his CFO role, he served as a Vice President and Controller from 1994 to 2005. Prior to 1994, Mr. Graner spent 20 years in various managerial positions in the Treasury, Accounting and Information systems departments at Graco Inc.
Mr. Graner serves on the board of directors of Wanner Engineering, Inc.
Mr. Graner received a B.S.B. and an M.B.A. from the University of Minnesota.
William R. Jellison - Senior Advisor
William R. Jellison served as Chief Financial Officer of Stryker Corporation, one of the world’s leading medical technology companies, from 2013 to 2016. Prior to joining Stryker, Mr. Jellison served as the Senior Vice President and Chief Financial Officer of Dentsply International, the world’s largest manufacturer of professional dental products, from 1998 to 2013, except for a roughly two year period of time between 2002 and 2005 when he was a Senior Vice President with full P&L responsibilities for some of Dentsply’s operating divisions located in the U.S., Europe and Asia.
Mr. Jellison began his career with the Donnelly Corporation, a publicly traded international automotive parts supplier, where he served in several senior leadership roles, advancing to Vice President of Finance.
Mr. Jellison serves on the board of directors of PolyOne Corporation.
Mr. Jellison received a B.A. Degree in Business Administration from Hope College in Michigan.
Frank A. "Andy" Wilson - Senior Advisor
Mr. Wilson was Senior Vice President and Chief Financial Officer of PerkinElmer, Inc., a life sciences diagnostics, discovery and analytical solutions company, from 2009 until his retirement in 2018.
Prior to joining PerkinElmer, he held key business development and finance roles over 12 years at the Danaher Corporation, including Corporate Vice President of Investor Relations.
Previously, Mr. Wilson worked for several years at AlliedSignal, Inc., now Honeywell International Inc., where he served as Vice President of Finance and Chief Financial Officer for Commercial Avionics Systems. His earlier experience included financial and controllership positions of increasing responsibility at PepsiCo Inc., as well as roles at E.F. Hutton and Company, and KPMG Peat Marwick.
Mr. Wilson is a member of the Board of Directors of Alkermes plc, a global biopharmaceutical company. He is also a member of the Board of Directors of Cabot Corporation, a leading global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. From 2015 to 2019, he was a member of the Board of Directors of Sparton Corporation where he served as Chairman of the Board for a period of time. Sparton Corporation was a formerly independent public company that designed and manufactured complex electromechanical devices.
Mr. Wilson is a Certified Public Accountant and holds a Bachelor of Business Administration and Accounting from Baylor University.
David M. Kelly - Senior Advisor
David M. Kelly served as the Chief Executive Officer and Chief Operating Officer of Matthews International Corporation from 1995 to 2006 and as Chairman of the Board from 1996 to 2008. Matthews International is a provider of memorialization products and brand solutions with $1.4 billion in annual sales.
Prior to Matthews International, Mr. Kelly worked at Carrier Corporation for 23 years, where he held a variety of executive positions in marketing, finance, manufacturing and operations.
Mr. Kelly currently serves on the board of directors of Mesa Laboratories Inc. and Mestek Inc. and previously served on the board of Duquesne Light Holdings Inc, Elliott Company and Federated Investors, Inc.
Mr. Kelly received a B.S. in Physics from Boston College, an M.S. degree in Molecular Biophysics from Yale University, and an M.B.A. from Harvard Business School.
Donald E. Morel, Jr. - Senior Advisor
Dr. Morel joined West Pharmaceutical Services Inc. in 1992 as Director of R&D and served as Chief Executive Officer from April 2002 and Chairman of the Board from March 2003 until his retirement in June 2015. He is widely recognized for his transformation of West and his leadership in the aftermath of the Kinston, NC, plant explosion and fire in 2003. During his tenure Dr. Morel and his team delivered significant shareholder value, generating a ten-fold increase in the company’s share price and market capitalization which grew from $380 million at the beginning of 2002 to more than $4.4 billion at his retirement.
Prior to joining West, Dr. Morel developed and managed a broad range of programs involving advanced materials for aerospace and biomedical applications. He has published more than thirty papers dealing with advanced composites and environmental effects on material performance. His aerospace work in the 1980’s resulted in his selection as a finalist for assignment as a NASA Mission Specialist in the Astronaut Office in 1989.
Dr. Morel serves on the board of directors of Integra LifeSciences Holdings Corporation and Catalent Corporation.
Dr. Morel holds a BS degree in Engineering from Lafayette College, an MS in Materials Science and a Ph.D. in Materials Science and Veterinary Medicine from Cornell University. He completed The Executive Program at the University of Virginia Darden School of Business.